Business Context and Reporting Period
Prestige Brands Holdings, Inc. (now Prestige Consumer Healthcare Inc.) filed this Form 8-K on September 12, 2005, reporting a material event that occurred on September 8, 2005. The filing details a strategic partnership with The Procter & Gamble Company (P&G) regarding specific trademark rights in Eastern Europe and Central Asia.
Key Financial Metrics
This filing is a Current Report (Form 8-K) and does not contain financial statements, revenue figures, profit margins, cash flow data, debt levels, or liquidity metrics. The document focuses exclusively on the execution of a material definitive agreement.
Material Changes and Agreements
On September 8, 2005, the Company entered into a Trademark License Agreement and Option to Purchase with P&G. Key terms include:
- Licensed Trademarks: Comet and Chlorinol.
- Scope: P&G is licensed to manufacture, market, use, sell, and distribute products under these trademarks in Russia, Ukraine, Belarus, Lithuania, Estonia, Latvia, Mongolia, Kazakhstan, Uzbekistan, Armenia, Azerbaijan, Georgia, Kyrgyzstan, Tajikistan, and Turkmenistan.
- Option to Purchase: P&G holds an option to purchase the trademarks. The purchase price is not fixed but will be based on a multiple of P&G's adjusted net sales of the products within the covered territory.
- Effective Date: The agreement is scheduled to become effective on January 1, 2006.
Outlook, Risks, and Management Commentary
The Company issued a press release on September 12, 2005, to announce the agreement. The filing notes that certain confidential portions of the agreement have been omitted pursuant to a confidential treatment request filed separately with the SEC. No specific financial guidance, risk factors, or management commentary regarding future performance was included in this specific filing text.
Investor Verification Checklist
- Verify the specific "multiple" formula used to calculate the potential purchase price of the trademarks, as this was redacted for confidential treatment.
- Confirm the exact product lines covered under the Comet and Chlorinol licenses in the specified territories.
- Review the full text of the attached Trademark License Agreement (Exhibit 10.1) for termination clauses and performance milestones.
- Assess the strategic impact of ceding distribution rights in these specific regions to a major competitor like P&G.